Records containing: Solid Tumor
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-09-10A Phase 1, Open-label, Non-Randomized, Dose Escalation Trial to Evaluate Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor
-
CLINICAL_TRIALS study record update · 2019-08-28A Phase I, Two-arm, Open-label, Single-center, Dose-escalation Study to Evaluate the Safety, Tolerability and Recommended Dose and Delivery Mode of the Pan-immunotherapy in Subjects With Unresectable/ Metastatic Solid Tumors or Lymphomas
-
CLINICAL_TRIALS study record update · 2019-08-28Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients
-
CLINICAL_TRIALS study record update · 2019-08-28A Phase 2 Study of AMG 337 in Subjects With Advanced or Metastatic Solid Tumors That Overexpress Mesenchymal Epithelial Transition (MET) or Harbor MET Exon 14 Skipping (METex14del) Mutations
-
CLINICAL_TRIALS study record update · 2019-08-22A Contiguous, Sequential Phase I/II Imaging Study of 18F-fluoro-3'-L-fluorothymidine (18F-FLT) in Patients With Known or Suspected Carcinoma of the Lung, Breast, Renal Cell, Pancreas, or Brain, and With Gastrointestinal Malignancies, Neuroendocrine Tumours or Lymphoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-08-12A Phase 1a/1b Study of CXCR4 Peptide Antagonist (LY2510924) Administered in Combination With the Anti-PD-L1 Antibody, Durvalumab (MEDI4736), in Advanced Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-08-06A Phase 0 Study to Investigate Biodistribution and Target Tissue Distribution Using Whole-body PET Scan After Oral Administration of Therapeutic Dose of Liporaxel Solution and Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor
-
CLINICAL_TRIALS study record update · 2019-08-06Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Cancer Patients
-
CLINICAL_TRIALS study record update · 2019-08-02A First-in-Human, Multicenter, Open-label, Phase 1 Dose-Escalation Study of LZM009 in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-07-23Phase I Clinical Trial of Camptothecin-20-O-Propionate Hydrate (CZ48)
-
CLINICAL_TRIALS study record update · 2019-07-23An Open-label, Multicenter Extension Study of Onartuzumab in Patients With Solid Tumors on Study Treatment Previously Enrolled in an F.Hoffmann-la Roche- and/or Genentech- Sponsored Study
-
CLINICAL_TRIALS study record update · 2019-07-23A Pilot Study to Determine the Biological Effects of Hydroxychloroquine on PAR-4 Levels in Patients With Resectable Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-06-28Phase1b/2 Study of AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer
-
CLINICAL_TRIALS study record update · 2019-06-19A Multicenter, Open Label, Uncontrolled Phase I Trial to Compare Safety, Tolerability and Immunogenicity of Vx-006 Vaccine at 0.5mg, 1mg, 5mg and 10mg Doses in Human Leukocyte Antigen-A02 (HLA-A02) Positive Patients With Solid Tumours
-
CLINICAL_TRIALS study record update · 2019-06-18Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 6 - BGJ398 for Patients With Tumors With FGFR Genetic Alterations
-
CLINICAL_TRIALS study record update · 2019-06-17Phase 1 Dose Escalation Study of LY2334737 Using 2 Dosing Regimens in Patients With Advanced and/or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-06-11Phase 1 Study of Combination Therapy With Mogamulizumab (KW-0761) and Nivolumab (ONO-4538/BMS-936558) in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-05-23A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (HLX10) in Combination With Recombinant Anti-VEGF Humanized Monoclonal Antibody Injection (HLX04) in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-05-20SAMSUNG MEDICAL CENTER
-
CLINICAL_TRIALS study record update · 2019-05-20AZD2014 in RICTOR Amplified Solid Cancer
-
CLINICAL_TRIALS study record update · 2019-05-08Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis: A Pilot Study
-
CLINICAL_TRIALS study record update · 2019-05-07Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-05-06Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
-
CLINICAL_TRIALS study record update · 2019-04-25A Phase 1/1b, Multicenter, Open-Label Study of Intravenous RXDX-107 in Adult Patients With Locally Advanced or Metastatic Solid Cancer
-
CLINICAL_TRIALS study record update · 2019-03-13A Phase 1a Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors